Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension

Peer Review reports

Original Submission
31 May 2023	Submitted	Original manuscript
16 Jun 2023	Reviewed	Reviewer Report
16 Jun 2023	Reviewed	Reviewer Report
12 Jul 2023	Author responded	Author comments - Gabriel Bsteh
Resubmission - Version 2
12 Jul 2023	Submitted	Manuscript version 2
Publishing
13 Jul 2023	Editorially accepted
18 Jul 2023	Article published	10.1186/s10194-023-01631-z

Back to article page